Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Cervical Cancer
100%
Cervical Intraepithelial Neoplasia Grade 3
42%
Cervical Neoplasia
14%
Confidence Interval
28%
CpG Methylation
28%
CpG Sites
42%
Dichotomization
14%
High-risk HPV
100%
High-risk Human Papillomavirus (HR-HPV)
100%
HIV-positive
28%
HIV-positive Women
100%
HPV DNA
14%
HPV Genome
14%
HPV Types
42%
HPV-45
14%
HPV-related Cancers
14%
HPV16
28%
HPV18
28%
HPV31
14%
HPV35
14%
L1-L2
28%
Methylation
100%
Methylation Assay
14%
Methylation Status
28%
Next-generation Sequencing
14%
Positive Control
14%
Risk Attribution
14%
Separate Control
14%
Triage
14%
Women's Interagency HIV Study
14%
Medicine and Dentistry
Cervical Intraepithelial Neoplasia
37%
Cohort Analysis
12%
Human Immunodeficiency Virus
100%
Human Papillomavirus Type 16
25%
Human Papillomavirus Type 18
25%
Human Papillomavirus Type 31
12%
Human Papillomavirus Type 35
12%
Human Papillomavirus Type 45
12%
Infection
25%
Methylation
100%
Neoplasm
12%
Next Generation Sequencing
12%
Precancerous Condition
100%
Triage
12%
Wart Virus
100%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
12%
HIV
100%
Human Papillomavirus
100%
Human Papillomavirus Type 16
25%
Human Papillomavirus Type 18
25%
Human Papillomavirus Type 31
12%
Human Papillomavirus Type 35
12%
Human Papillomavirus Type 45
12%
Infection
25%
Neoplasm
12%
Precancer
100%
Uterine Cervix Carcinoma in Situ
37%
Biochemistry, Genetics and Molecular Biology
Cohort Study
12%
CpG Site
37%
Human Immunodeficiency Virus
100%
Human Papillomavirus Type 16
25%
Human Papillomavirus Type 18
25%
Human Papillomavirus Type 31
12%
Human Papillomavirus Type 35
12%
Human Papillomavirus Type 45
12%
Methylation
100%
Next Generation Sequencing
12%
Wart Virus
100%
Neuroscience
Cervical Intraepithelial Neoplasia
37%
CpG Site
37%
Human Immunodeficiency Virus
100%
Human Papillomavirus
100%
Methylation
100%